Cargando…

Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder

Genetic variation in the cholinergic-muscarinic2 (M(2))receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannon, DM, Klaver, JK, Gandhi, SK, Solorio, G, Peck, SA, Erickson, K, Savitz, J, Akula, N, Eckelman, WC, Furey, ML, Sahakian, BJ, McMahon, FJ, Drevets, WC
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895691/
https://www.ncbi.nlm.nih.gov/pubmed/20351719
http://dx.doi.org/10.1038/mp.2010.24
_version_ 1782183282020974592
author Cannon, DM
Klaver, JK
Gandhi, SK
Solorio, G
Peck, SA
Erickson, K
Savitz, J
Akula, N
Eckelman, WC
Furey, ML
Sahakian, BJ
McMahon, FJ
Drevets, WC
author_facet Cannon, DM
Klaver, JK
Gandhi, SK
Solorio, G
Peck, SA
Erickson, K
Savitz, J
Akula, N
Eckelman, WC
Furey, ML
Sahakian, BJ
McMahon, FJ
Drevets, WC
author_sort Cannon, DM
collection PubMed
description Genetic variation in the cholinergic-muscarinic2 (M(2))receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects with major depressive disorder (MDD) and healthy controls (1). In the current study we investigated the effects of six single nucleotide polymorphisms (SNP) for CHRM2 on M(2)-receptor binding to test the hypotheses that genetic variation in CHRM2 influences M(2)-receptor binding and that a CHRM2 polymorphism underlies the deficits in M(2)-receptor V(T) observed in BD. The M(2)-receptor V(T) was measured using PET and [(18)F]FP-TZTP in unmedicated, depressed subjects with BD (n=16) or MDD (n=24) and healthy controls (n=25), and the effect of genotype on V(T) was assessed. In the controls one SNP (with identifier rs324650, in which the ancestral allele adenine (A) is replaced with one or two copies of thymine (T), showed a significant allelic effect on V(T) in the pregenual and subgenual anterior cingulate cortices in the direction AA<AT<TT. In contrast, in BD subjects with the TT-genotype V(T) was significantly lower than in BD subjects with the AT-genotype in these regions. The BD subjects homozygous for the T-allele also showed markedly lower V(T) (by 27 to 37% across regions) than healthy controls of the same genotype. Post hoc analyses suggested that T homozygosity was associated with a more severe illness course, as manifested by lower socioeconomic function, poorer spatial recognition memory and a greater likelihood of having attempted suicide. These data represent novel preliminary evidence that reduced M(2)-receptor V(T) in BD is associated with genetic variation within CHRM2. The differential impact of the M(2)-receptor polymorphism at rs324650 in the BD and HC samples suggests interactive effects with an unidentified vulnerability-factor for BD.
format Text
id pubmed-2895691
institution National Center for Biotechnology Information
language English
publishDate 2010
record_format MEDLINE/PubMed
spelling pubmed-28956912011-10-01 Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder Cannon, DM Klaver, JK Gandhi, SK Solorio, G Peck, SA Erickson, K Savitz, J Akula, N Eckelman, WC Furey, ML Sahakian, BJ McMahon, FJ Drevets, WC Mol Psychiatry Article Genetic variation in the cholinergic-muscarinic2 (M(2))receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects with major depressive disorder (MDD) and healthy controls (1). In the current study we investigated the effects of six single nucleotide polymorphisms (SNP) for CHRM2 on M(2)-receptor binding to test the hypotheses that genetic variation in CHRM2 influences M(2)-receptor binding and that a CHRM2 polymorphism underlies the deficits in M(2)-receptor V(T) observed in BD. The M(2)-receptor V(T) was measured using PET and [(18)F]FP-TZTP in unmedicated, depressed subjects with BD (n=16) or MDD (n=24) and healthy controls (n=25), and the effect of genotype on V(T) was assessed. In the controls one SNP (with identifier rs324650, in which the ancestral allele adenine (A) is replaced with one or two copies of thymine (T), showed a significant allelic effect on V(T) in the pregenual and subgenual anterior cingulate cortices in the direction AA<AT<TT. In contrast, in BD subjects with the TT-genotype V(T) was significantly lower than in BD subjects with the AT-genotype in these regions. The BD subjects homozygous for the T-allele also showed markedly lower V(T) (by 27 to 37% across regions) than healthy controls of the same genotype. Post hoc analyses suggested that T homozygosity was associated with a more severe illness course, as manifested by lower socioeconomic function, poorer spatial recognition memory and a greater likelihood of having attempted suicide. These data represent novel preliminary evidence that reduced M(2)-receptor V(T) in BD is associated with genetic variation within CHRM2. The differential impact of the M(2)-receptor polymorphism at rs324650 in the BD and HC samples suggests interactive effects with an unidentified vulnerability-factor for BD. 2010-03-30 2011-04 /pmc/articles/PMC2895691/ /pubmed/20351719 http://dx.doi.org/10.1038/mp.2010.24 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Cannon, DM
Klaver, JK
Gandhi, SK
Solorio, G
Peck, SA
Erickson, K
Savitz, J
Akula, N
Eckelman, WC
Furey, ML
Sahakian, BJ
McMahon, FJ
Drevets, WC
Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
title Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
title_full Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
title_fullStr Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
title_full_unstemmed Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
title_short Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
title_sort genetic variation in cholinergic-muscarinic-2 receptor gene modulates muscarinic(2)-receptor binding in vivo and accounts for reduced binding in bipolar disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895691/
https://www.ncbi.nlm.nih.gov/pubmed/20351719
http://dx.doi.org/10.1038/mp.2010.24
work_keys_str_mv AT cannondm geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT klaverjk geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT gandhisk geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT soloriog geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT pecksa geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT ericksonk geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT savitzj geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT akulan geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT eckelmanwc geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT fureyml geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT sahakianbj geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT mcmahonfj geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder
AT drevetswc geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder